Taub Rebecca sold MDGL
January 9, 2026 · Form 4 insider transaction
Taub Rebecca sold 1,335 shares of Madrigal Pharmaceuticals, Inc. at $524.06 per share, a transaction worth $699.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,335
Price
$524.06
Total value
$699.6K
InsiderTaub Rebecca
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 9, 2026
Filing dateJanuary 13, 2026
Shares owned after462,395
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.59 to $524.58, inclusive.